In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Albireo Pharma (ALBO – Research Report), with a price target of $80.00. The company's shares closed last Thursday at $25.86. According to TipRanks.com, Arce is a 4-star analyst with an average return of 14.6% and a 38.7% success rate. Arce covers the Healthcare sector, focusing on stocks such as Entasis Therapeutics Holdings, Madrigal Pharmaceuticals, and Paratek Pharmaceuticals. Currently, the analyst consensus on Albireo Pharma is a Strong Buy with an average price target of $79.00, a 217.1% upside from current levels.
https://www.tipranks.com/news/blurbs/albireo-pharma-albo-receives-a-buy-from-h-c-wainwright-2?utm_source=advfn.com&utm_medium=referral